Inteligex Founder and President Dr. Michael Fehlings was featured on the Optimal NeuroSpine Podcast. Listen to the discussion on recent advances in spinal cord injury, the importance of translational research, and the promise of stem cell therapy. #SCI https://www.buzzsprout.com/1771041/8607049

New publication: Indicators of Quality of Care in Individuals With Traumatic Spinal Cord Injury: A Scoping Review #spine #research #health #SCI
https://pubmed.ncbi.nlm.nih.gov/33487062/

New publication: Indicators of Quality of Care in Individuals With Traumatic Spinal Cord Injury: A Scoping Review https://pubmed.ncbi.nlm.nih.gov/33487062/ #spine #SCI @UofTSpine @KrembilRI @Inteligex2

Neurons derived from transplanted SMaRT cells (shown here as both green and red cells) form connections and communicate in spinal cord tissue. Inteligex's proprietary SMaRT cells are bioengineered to address the key barriers to regeneration after spinal cord injury. #SCI #science

Congratulations to Inteligex CMO and CEO, Dr. Chris Ahuja, on being recognized with the Golden Scalpel Award from the Canadian Association of Chairs of Surgical Research!!!

http://cacsr.ca/golden-scalpel-award/

Check out Inteligex's website to learn more about the exciting work being done in Toronto!! #spinalcordinjury #SCI #stemcells #regeneration #innovation #Toronto

https://www.inteligex.ca/

load more...